entertainment -WSS

entertainment

author：comprehensive 2025-08-12 09:08:33 - browse：4

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Republicans love RFK Jr. What's that tell us about health in 2024?

WSS

Why Novartis is changing the name of its research labs

Why Novartis is changing the name of its research labs

What drug price negotiations mean for Medicare Part D

PBMs are inflating the cost of generic drugs. They must be reined in

ALS advocates say criticism of new drugs misses bigger picture

Vivek Ramaswamy made waves in the debate, much as in biotech

entertainment

entertainment

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How to protect patients from sexual assault

Supreme Court strikes down use of affirmative action

How to protect patients from sexual assault

State Dept. review finds Biden bears some blame for Afghanistan failures

Trump surgeon general acknowledges mistakes during Covid

New air purifier tech could be key to improving indoor air quality

Former Pear Therapeutics executives start new VC firm

Continuity nursing helped my family in our darkest PICU moments

Hospital at home shows how to bring innovation to health care

hotspot

Roche's accidental data boosts hopes for anti

Vivek Ramaswamy made waves in the debate, much as in biotech

Republicans love RFK Jr. What's that tell us about health in 2024?

Meadows told special counsel he could not recall Trump ever declassifying Mar

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Former Pear Therapeutics executives start new VC firm

knowledge

hotspot

focus

focus